Georgia ProtonCare Center Inc. has filed for Chapter 11 bankruptcy protection as part of a plan to sell its Midtown Atlanta proton therapy facility to Emory University Hospital Midtown.

As part of the filing, the company has entered into an asset purchase agreement with Emory, which will serve as the initial or “stalking horse” bidder in a court-supervised sale process under Section 363 of the U.S. Bankruptcy Code. The agreement includes the sale of substantially all of the company’s assets and the assumption of certain liabilities.

The Atlanta-based facility, the only proton therapy center in Georgia, is currently staffed by Emory clinicians, who will continue delivering care during the proceedings. The sale process is expected to conclude in the second quarter of 2026, pending approval from the U.S. Bankruptcy Court for the Northern District of Georgia.
GPCC has appointed Darryl Myers of BDO Consulting Group as chief restructuring officer to lead the process. In a statement, Myers said, “GPCC’s management team and board have evaluated all of our strategic options and believe that this option is in the best interest of patients, the community, and other stakeholders. Our top priority is to ensure the uninterrupted treatment of cancer patients at the center. We are confident that Emory, if they are the ultimate acquirer, will be able to seamlessly continue serving our patients’ needs."

The company plans to maintain normal operations and has filed motions to pay employees, vendors and other core expenses. GPCC will use cash collateral from its bondholders to fund operations during the restructuring, with consent from bond trustee UMB Bank.

Polsinelli PC is advising GPCC as legal counsel, with BDO serving as financial advisor and SOLIC Capital as investment banker. UMB Bank is represented by Mintz Levin and Houlihan Lokey.

Proton Therapy Homepage